| Literature DB >> 32411283 |
Xiaoping Tang1, Xinlan Xiao1, Jianhua Yin1, Ting Yang1, Bingliang Zeng2.
Abstract
In order to assess the relationship between structural and functional imaging of cerebrovascular disease and cognition-related fibers, this paper chooses a total of 120 patients who underwent cerebral small vessel disease (CSVD) treatment at a designated hospital by this study from June 2013 to June 2018 and divides them into 3 groups according to the random number table method: vascular dementia (VaD) group, vascular cognitive impairment no dementia (VCIND) group, and noncognition impairment (NCI) group with 40 cases of patients in each group. Cognitive function measurement and imaging examination were performed for these 3 groups of patients, and the observation indicators of cognitive state examination (CSE), mental assessment scale (MAS), clock drawing test (CDT), adult intelligence scale (AIS), frontal assessment battery (FAB), verbal fluency test (VFT), trail making test (TMT), cognitive index (CI), white matter lesions (WML), third ventricle width (TVW), and frontal horn index (FHI) were tested, respectively. The results shows that the average scores of CSE, MAS, AIS, and VFT in the VaD and VCIND group are lower than those of the NCI group and the differences are statistically significant (P < 0.05); the average scores of FAB, TMT, and CI in the VaD group are higher than those of the VCIND group and the differences are also statistically significant (P < 0.05); the average scores of FHI and TVW in the VaD group are lower than those of the VCIND and NCI group with statistically significant differences (P < 0.05); the average scores of WML, CDT, and AIS in the VaD group are higher than those of the VCIND and NCI group with statistically significant differences (P < 0.05). Therefore, it is believed that the structural and functional imaging features of cerebrovascular disease are closely related to cognition-related fibers, and the incidence of white matter lesions is closely related to the degree of lesions and cognitive dysfunction of cerebral small vessel disease, in which a major risk factor for cognitive dysfunction in patients with small blood vessels is the severity of white matter lesions; brain imaging and neuropsychiatric function assessment can better understand the relationship between cerebrovascular disease and cognitive impairment. The results of this study provide a reference for the further research studies on the relationship between structural and functional imaging of cerebrovascular disease and cognition-related fibers.Entities:
Mesh:
Year: 2020 PMID: 32411283 PMCID: PMC7201792 DOI: 10.1155/2020/4347676
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
General information of SIVD patients in VaD, VCIND, and NCI group ( ± s).
| Group | Average age (years old) | Gender (male/female) | ADL | CSE | MAS | Education level | ||
|---|---|---|---|---|---|---|---|---|
| PSB | JHS | HSA | ||||||
| VaD | 66.27 ± 5.67 | 23/17 | 28.17 ± 1.59 | 20.06 ± 3.84 | 24.52 ± 3.84 | 2 | 22 | 16 |
| VCIND | 66.32 ± 5.64 | 24/16 | 28.04 ± 1.62 | 19.79 ± 3.71 | 24.57 ± 2.63 | 5 | 17 | 28 |
| NCI | 66.48 ± 5.67 | 20/20 | 24.33 ± 2.57 | 84.97 ± 5.31 | 24.33 ± 2.57 | 7 | 15 | 28 |
|
| >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||
PSB: primary school and below; JHS: junior high school; HAS: high school and above.
Figure 1Framework of detecting the relationship between structural and functional imaging of cerebrovascular disease and cognition-related fibers.
Comparison of TVW, AIS, VFT, and TMT in the VaD, VCIND, and NCI patients ( ± s).
| Group | Treatment time | TVW | AIS | VFT | TMT |
|---|---|---|---|---|---|
| VaD ( | Before treatment | 0.96 ± 0.23 | 1.52 ± 0.49 | 10.27 ± 3.17 | 123.63 ± 57.73 |
| After 6 months of treatment | 0.93 ± 0.21 | 1.36 ± 0.38 | 12.46 ± 2.19 | 122.15 ± 45.38 | |
| After 12 months of treatment | 0.84 ± 0.19 | 1.63 ± 0.11 | 15.13 ± 2.14 | 120.77 ± 54.69 | |
| VCIND ( | Before treatment | 0.91 ± 0.22 | 1.68 ± 0.39 | 11.14 ± 3.12 | 123.55 ± 56.87 |
| After 6 months of treatment | 0.88 ± 0.21 | 1.57 ± 0.27 | 13.03 ± 2.06 | 121.89 ± 45.44 | |
| After 12 months of treatment | 0.82 ± 0.18 | 1.21 ± 0.63 | 16.44 ± 2.16 | 120.32 ± 54.76 | |
| NCI ( | Before treatment | 0.80 ± 0.19 | 1.79 ± 0.41 | 15.03 ± 3.06 | 123.46 ± 46.35 |
| After 6 months of treatment | 0.81 ± 0.17 | 1.80 ± 0.24 | 15.75 ± 2.04 | 115.57 ± 55.01 | |
| After 12 months of treatment | 0.79 ± 0.16 | 1.87 ± 0.36 | 16.72 ± 2.13 | 111.47 ± 45.32 | |
|
| 0.163/0.028 | 0.325/0.003 | 0.754/0.003 | 0.855/0.016 | |
|
| 0.174/0.005 | 0.542/0.018 | 0.584/0.027 | 0.585/0.027 | |
|
| 0.164/0.002 | 0.234/0.003 | 0.234/0.015 | 0.584/0.005 | |
|
| 0.471/0.013 | 0.422/0.014 | 0.742/0.003 | 0.234/0.023 | |
|
| 0.315/0.001 | 0.512/0.032 | 0.284/0.002 | 0.679/0.015 |
Comparison of CI, FAB, WML, and FHI in the VaD, VCIND, and NCI patients ( ± s).
| Group | Treatment time | CI | FAB | WML | FHI |
|---|---|---|---|---|---|
| VaD ( | Before treatment | 5.92 ± 0.89 | 11.41 ± 2.34 | 14.15 ± 3.23 | 3.43 ± 0.63 |
| After 6 months of treatment | 5.58 ± 0.81 | 11.57 ± 2.53 | 9.54 ± 2.35 | 3.75 ± 0.58 | |
| After 12 months of treatment | 5.14 ± 0.69 | 11.64 ± 2.77 | 3.63 ± 2.47 | 3.95 ± 0.29 | |
| VCIND ( | Before treatment | 5.28 ± 0.84 | 11.45 ± 2.44 | 11.34 ± 3.16 | 3.55 ± 0.87 |
| After 6 months of treatment | 5.16 ± 0.81 | 11.53 ± 2.34 | 7.68 ± 2.33 | 3.84 ± 0.64 | |
| After 12 months of treatment | 5.09 ± 0.78 | 11.57 ± 2.70 | 3.55 ± 2.45 | 4.01 ± 0.46 | |
| NCI ( | Before treatment | 5.05 ± 0.88 | 11.44 ± 2.44 | 3.10 ± 3.55 | 4.06 ± 0.35 |
| After 6 months of treatment | 5.03 ± 0.67 | 11.56 ± 2.83 | 2.34 ± 2.27 | 4.07 ± 0.51 | |
| After 12 months of treatment | 5.02 ± 0.66 | 11.63 ± 2.54 | 2.67 ± 2.68 | 4.09 ± 0.32 | |
|
| 0.758/0.001 | 0.660/0.014 | 0.116/0.016 | 0.855/0.001 | |
|
| 0.431/0.011 | 0.357/0.006 | 0.775/0.007 | 0.465/0.015 | |
|
| 0.297/0.024 | 0.486/0.001 | 0.248/0.001 | 0.784/0.020 | |
|
| 0.644/0.001 | 0.355/0.022 | 0.351/0.014 | 0.694/0.010 | |
|
| 0.586/0.014 | 0.622/0.001 | 0.896/0.001 | 0.579/0.001 |
Figure 2Analysis results of the relationship between structural imaging of cerebrovascular disease and cognition-related fibers. (a) The relationship between CSE and ADL score in the VaD group of patients. (b) The relationship between CSE and MAS score in the VaD group of patients.
Figure 3Result analysis of the relationship between functional imaging of cerebrovascular disease and cognition-related fibers (for the abbreviations, refer to the context).
Correlation analysis between neuropsychological scale score and degree of white matter lesions.
| Indicators | VaD | VCIND | NCI |
|
|
|---|---|---|---|---|---|
| CSE | 0.43 | 0.24 | −0.35 | 17.78 | 0.26 |
| MAS | −0.35 | 0.37 | −0.59 | 10.64 | 0.13 |
| CDT | 0.71 | 0.68 | 0.66 | 46.66 | 0.27 |
| DST | −0.29 | 0.55 | 0.19 | 23.17 | 0.09 |
| FAB | 0.32 | 0.46 | 0.22 | 19.35 | 0.01 |
| VFT | −0.67 | −0.74 | −0.45 | 12.55 | 0.05 |
| CWT | −0.54 | −0.62 | −0.84 | 10.28 | 0.25 |
| RT | −0.39 | −0.56 | −0.75 | 11.45 | 0.06 |
| TE | −0.21 | −0.63 | −0.53 | 14.46 | 0.13 |
| T1W1 | 0.38 | −0.30 | 0.74 | 16.85 | 0.04 |
| T2W2 | 0.46 | −0.28 | 0.11 | 13.57 | 0.06 |
| DWI | 0.57 | −0.76 | −0.54 | 36.68 | 0.03 |
| FVO | −0.11 | 0.36 | −0.64 | 44.58 | 0.12 |
| TMT | −0.57 | 0.56 | −0.78 | 15.43 | 0.01 |
| CI | −0.33 | 0.76 | 0.63 | 14.66 | 0.31 |
| WML | 0.79 | 0.44 | 0.37 | 17.28 | 0.12 |
| TVW | 0.43 | −0.12 | 0.45 | 15.69 | 0.09 |
| FHI | 0.29 | −0.49 | 0.52 | 18.73 | 0.02 |
Figure 4Correlation between the scores of neuropsychological scales and the degree of white matter lesions. (a) The relationship between TVM and AIS score. (b) The relationship between VFT and TMT score. (c) The relationship between CI and FAB score. (d) The relationship between MWL and FHI score. “r” and “p” were correlation coefficient and degree of fit, respectively.
Figure 5Evolution of key indicator relativity with treatment duration. (a) VaD group. (b) VCIND group.